Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 318
Filtrar
1.
Food Chem Toxicol ; 190: 114786, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38849048

RESUMEN

Continuous dopaminergic stimulation (CDS) has become an important strategy for the development of drugs to treat Parkinson's disease (PD). Rotigotine behenate extended-release microspheres (RBEM) for injection represents a new treatment regime for CDS and is being applied for clinical trial. Our study in cynomolgus monkeys was a 20-week repeat dose toxicity investigation with RBEM at dosages of 90, 180, 360, with a 12-week recovery period. The results observed some irritations in the application site and surrounding tissues in Placebo microspheres and each dose of RBEM, was accompanied with increased white blood count and fibrinogen. RBEM-treated monkeys were additionally noted with a pharmacological action-related decrease in prolactin. These findings showed certain reversibility after the 12-week recovery phase. No clear sex difference was noted in the plasma exposure to rotigotine. The exposure generally increased in a dose-proportional manner. In summary, major toxicological effects are associated with the dopamine agonist-related properties of rotigotine, and the removal of foreign bodies caused by p oly (lactide-co-glycolide) (PLGA)and sodium carboxymethyl cellulose (SCMC), and the no-observed-adverse-effect-level (NOAEL) was 360 mg/kg.


Asunto(s)
Preparaciones de Acción Retardada , Agonistas de Dopamina , Macaca fascicularis , Microesferas , Tetrahidronaftalenos , Tiofenos , Animales , Tiofenos/toxicidad , Tiofenos/administración & dosificación , Tetrahidronaftalenos/toxicidad , Tetrahidronaftalenos/administración & dosificación , Masculino , Agonistas de Dopamina/toxicidad , Agonistas de Dopamina/administración & dosificación , Femenino , Inyecciones Intramusculares , Relación Dosis-Respuesta a Droga
2.
J Hazard Mater ; 460: 132444, 2023 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-37660621

RESUMEN

There is concern about the large amounts of aromatic compounds emitted during coking. Previous studies of coking emissions have been focused on polycyclic aromatic hydrocarbons, dioxin-like compounds, phenols, and volatile organic compounds, but previously unidentified compounds produced during coking may also harm human health. Here, the main pollutants in 69 soil samples from an abandoned coking plant were identified by non-target screening using two-dimensional gas chromatography time-of-flight mass spectrometry. Polycyclic aromatic hydrocarbons, long-chain alkanes, and thiophenes were dominant. High concentrations of thiophenes (benzothiophenes, dibenzothiophenes, and benzonaphtholthiophenes) were found. Quantitative analysis of 12 thiophenes (selected because of their concentrations and detection frequencies) was performed, and the concentrations were 0.03-647 µg/g dry weight, which were extremely high compared with concentrations in soil from uncontaminated sites and other industrial sites. Dibenzothiophene and benzo[b]naphtho[2,1-d]thiophene were dominant, accounting for 69% of the total thiophene concentration. Thiophene profiles in very contaminated areas were different from the profile in coal but similar to the profile in tar. Thiophenes in soil at the coking plant may have been supplied in tar leaks, wastewater, coke oven gases, and exhaust gases. A toxicity assessment indicated a strong likelihood of oxidative stress being induced by exposure to multiple thiophenes at the coking plant. The results suggest that thiophene emissions from coking plants should attract more attention than currently.


Asunto(s)
Coque , Hidrocarburos Policíclicos Aromáticos , Gases , Suelo , Tiofenos/toxicidad
3.
Sci Total Environ ; 879: 162924, 2023 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-36933742

RESUMEN

Polycyclic aromatic sulfur heterocyclic compounds (PASHs) belong among ubiquitous environmental pollutants; however, their toxic effects remain poorly understood. Here, we studied the aryl hydrocarbon receptor (AhR)-mediated activity of dibenzothiophene, benzo[b]naphtho[d]thiophenes, and naphthylbenzo[b]thiophenes, as well as their presence in two types of environmental matrices: river sediments collected from both rural and urban areas, and in airborne particulate matter (PM2.5) sampled in cities with different levels and sources of pollution. Benzo[b]naphtho[2,1-d]thiophene, benzo[b]naphtho[2,3-d]thiophene, 2,2-naphthylbenzo[b]thiophene, and 2,1-naphthylbenzo[b]thiophene were newly identified as efficient AhR agonists in both rat and human AhR-based reporter gene assays, with 2,2-naphthylbenzo[b]thiophene being the most potent compound identified in both species. Benzo[b]naphtho[1,2-d]thiophene and 3,2-naphthylbenzo[b]thiophene elicited AhR-mediated activity only in the rat liver cell model, while dibenzothiophene and 3,1-naphthylbenzo[b]thiophene were inactive in either cell type. Independently of their ability to activate the AhR, benzo[b]naphtho[1,2-d]thiophene, 2,1-naphthylbenzo[b]thiophene, 3,1-naphthylbenzo[b]thiophene, and 3,2-naphthylbenzo[b]thiophene inhibited gap junctional intercellular communication in a model of rat liver epithelial cells. Benzo[b]naphtho[d]thiophenes were dominant PASHs present in both PM2.5 and sediment samples, with benzo[b]naphtho[2,1-d]thiophene being the most abundant one, followed by benzo[b]naphtho[2,3-d]thiophene. The levels of naphthylbenzo[b]thiophenes were mostly low or below detection limit. Benzo[b]naphtho[2,1-d]thiophene and benzo[b]naphtho[2,3-d]thiophene were identified as the most significant contributors to the AhR-mediated activity in the environmental samples evaluated in this study. Both induced nuclear translocation of the AhR, and they induced CYP1A1 expression in a time-dependent manner, suggesting that their AhR-mediated activity may depend on the rate of their intracellular metabolism. In conclusion, some PASHs could be significant contributors to the overall AhR-mediated toxicity of complex environmental samples suggesting that more attention should be paid to the potential health impacts of this group of environmental pollutants.


Asunto(s)
Contaminantes Ambientales , Compuestos Heterocíclicos , Humanos , Ratas , Animales , Receptores de Hidrocarburo de Aril , Tiofenos/toxicidad , Tiofenos/metabolismo , Material Particulado
4.
J Med Chem ; 65(3): 2471-2496, 2022 02 10.
Artículo en Inglés | MEDLINE | ID: mdl-35077178

RESUMEN

Novel analogues of C-2-substituted thienopyrimidine-based bisphosphonates (C2-ThP-BPs) are described that are potent inhibitors of the human geranylgeranyl pyrophosphate synthase (hGGPPS). Members of this class of compounds induce target-selective apoptosis of multiple myeloma (MM) cells and exhibit antimyeloma activity in vivo. A key structural element of these inhibitors is a linker moiety that connects their (((2-phenylthieno[2,3-d]pyrimidin-4-yl)amino)methylene)bisphosphonic acid core to various side chains. The structural diversity of this linker moiety, as well as the side chains attached to it, was investigated and found to significantly impact the toxicity of these compounds in MM cells. The most potent inhibitor identified was evaluated in mouse and rat for liver toxicity and systemic exposure, respectively, providing further optimism for the potential value of such compounds as human therapeutics.


Asunto(s)
Antineoplásicos/uso terapéutico , Inhibidores Enzimáticos/uso terapéutico , Geranilgeranil-Difosfato Geranilgeraniltransferasa/antagonistas & inhibidores , Mieloma Múltiple/tratamiento farmacológico , Pirimidinas/uso terapéutico , Tiofenos/uso terapéutico , Animales , Antineoplásicos/síntesis química , Antineoplásicos/metabolismo , Antineoplásicos/toxicidad , Células de la Médula Ósea/efectos de los fármacos , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/metabolismo , Inhibidores Enzimáticos/toxicidad , Femenino , Proteínas Fúngicas/antagonistas & inhibidores , Proteínas Fúngicas/metabolismo , Geranilgeranil-Difosfato Geranilgeraniltransferasa/metabolismo , Humanos , Hígado/efectos de los fármacos , Masculino , Ratones Endogámicos C57BL , Estructura Molecular , Unión Proteica , Pirimidinas/síntesis química , Pirimidinas/metabolismo , Pirimidinas/toxicidad , Ratas , Saccharomyces cerevisiae/enzimología , Relación Estructura-Actividad , Tiofenos/síntesis química , Tiofenos/metabolismo , Tiofenos/toxicidad
5.
Pak J Pharm Sci ; 34(4): 1403-1407, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34799314

RESUMEN

α- ß unsaturated carboxylic acids containing a heterocyclic moiety is one of the most potent class of bioactive compounds whose speedy generation through novel synthetic techniques has become an enigma for the synthetic chemists. This research project demonstrates a novel method for the synthesis of these compounds using polymer-supported microwave-assisted methodology carried out through one-pot multicomponent reaction. Both soluble and insoluble polymers have been used and their results are comprehensively analyzed. Moreover, the compounds are characterized through spectral analysis like FTIR, GC-MASS, 1HNMR Spectroscopy. The cytotoxicity of synthesized compounds is evaluated through MTT assay using HEPG 2 cells.


Asunto(s)
Ácidos Carboxílicos/química , Citotoxinas/síntesis química , Tiofenos/síntesis química , Ácidos Carboxílicos/toxicidad , Citotoxinas/toxicidad , Cromatografía de Gases y Espectrometría de Masas , Células Hep G2/efectos de los fármacos , Humanos , Espectroscopía de Resonancia Magnética , Microondas , Polímeros , Espectroscopía Infrarroja por Transformada de Fourier , Tiofenos/toxicidad
6.
Int J Mol Sci ; 22(22)2021 Nov 16.
Artículo en Inglés | MEDLINE | ID: mdl-34830252

RESUMEN

Succinate dehydrogenase inhibitor (SDHI) fungicides are increasingly used in agriculture to combat molds and fungi, two major threats to both food supply and public health. However, the essential requirement for the succinate dehydrogenase (SDH) complex-the molecular target of SDHIs-in energy metabolism for almost all extant eukaryotes and the lack of species specificity of these fungicides raise concerns about their toxicity toward off-target organisms and, more generally, toward the environment. Herein we review the current knowledge on the toxicity toward zebrafish (Brachydanio rerio) of nine commonly used SDHI fungicides: bixafen, boscalid, fluxapyroxad, flutolanil, isoflucypram, isopyrazam, penthiopyrad, sedaxane, and thifluzamide. The results indicate that these SDHIs cause multiple adverse effects in embryos, larvae/juveniles, and/or adults, sometimes at developmentally relevant concentrations. Adverse effects include developmental toxicity, cardiovascular abnormalities, liver and kidney damage, oxidative stress, energy deficits, changes in metabolism, microcephaly, axon growth defects, apoptosis, and transcriptome changes, suggesting that glycometabolism deficit, oxidative stress, and apoptosis are critical in the toxicity of most of these SDHIs. However, other adverse outcome pathways, possibly involving unsuspected molecular targets, are also suggested. Lastly, we note that because of their recent arrival on the market, the number of studies addressing the toxicity of these compounds is still scant, emphasizing the need to further investigate the toxicity of all SDHIs currently used and to identify their adverse effects and associated modes of action, both alone and in combination with other pesticides.


Asunto(s)
Anomalías Múltiples/inducido químicamente , Metabolismo Energético/efectos de los fármacos , Inhibidores Enzimáticos/toxicidad , Proteínas de Peces/antagonistas & inhibidores , Fungicidas Industriales/toxicidad , Succinato Deshidrogenasa/antagonistas & inhibidores , Anomalías Múltiples/genética , Anomalías Múltiples/patología , Amidas/toxicidad , Anilidas/toxicidad , Animales , Compuestos de Bifenilo/toxicidad , Embrión no Mamífero , Proteínas de Peces/genética , Proteínas de Peces/metabolismo , Expresión Génica , Niacinamida/análogos & derivados , Niacinamida/toxicidad , Norbornanos/toxicidad , Pirazoles/toxicidad , Succinato Deshidrogenasa/genética , Succinato Deshidrogenasa/metabolismo , Tiazoles/toxicidad , Tiofenos/toxicidad , Pez Cebra
7.
Mutagenesis ; 36(6): 401-406, 2021 11 29.
Artículo en Inglés | MEDLINE | ID: mdl-34516639

RESUMEN

The repeated-dose liver micronucleus (RDLMN) assay is a novel method for detecting genotoxic chemicals. Two carcinogens methyl carbamate (MC) and 1,3-propane sultone (PS) were evaluated for the liver micronucleus in a 14-day repeated-dose study with Crl: CD (SD) IGS rats. Additionally, micronucleated reticulocytes (MN-RET) in peripheral blood and DNA damage (alkaline comet assay) in the liver were also assessed in the same animals. Ten groups of five male Crl: CD (SD) IGS rats were treated once daily with MC (300, 600 or 1200 mg/kg/day), PS (37.5, 75 or 150 mg/kg/day), negative control or three positive controls by oral gavage for 15 days. Blood samples were collected at 3 h after the last administration for determining MN-RET frequencies (%MN-RET), and the livers were sampled for determining the frequency of micronuclei and DNA damage. MC was negative in the comet assay, liver micronucleus assay and reticulocyte micronucleus assay, while PS was positive in all three assays. These results are consistent with the previous genotoxic findings of MC and PS. Therefore, the liver micronucleus assay can be effectively integrated into repeated-dose studies in animals. Moreover, integration of multiple genotoxicity end points into one study can reduce the number of animals, boost the experimental efficiency, and provides a comprehensive evaluation of the genotoxic potential of chemicals.


Asunto(s)
Carbamatos/toxicidad , Núcleo Celular/efectos de los fármacos , Hígado/efectos de los fármacos , Reticulocitos/efectos de los fármacos , Tiofenos/toxicidad , Animales , Carcinógenos/toxicidad , Aberraciones Cromosómicas , Ensayo Cometa/métodos , Daño del ADN , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Masculino , Pruebas de Micronúcleos/métodos , Ratas , Ratas Sprague-Dawley
8.
ACS Appl Mater Interfaces ; 13(34): 41012-41020, 2021 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-34410119

RESUMEN

Photodynamic therapy (PDT) is a potential approach to resolve antibiotic resistance, and phenylene/thiophene-ethynylene oligomers have been widely studied as effective antibacterial reagents. Oligomers with thiophene moieties usually exhibit good antibacterial activity under light irradiation and dark conditions. In the previous study, we verified that neutral oligo-p-phenylene-ethynylenes (OPEs) exhibit better antibacterial activity than the corresponding cationic ones; however, whether this regular pattern also operates in other kinds of oligomers such as oligo-thiophene-ethynylene (OTE) is unknown. Also, the antibacterial activity comparison of OTEs bearing cyclic and acyclic amino groups will offer useful information to further understand the role of amino groups in the antibacterial process and guide the antibacterial reagent design as amino groups affect the antibacterial activity a lot. We synthesized four OTEs bearing neutral or cationic, cyclic, or acyclic amino groups and studied their antibacterial activity in detail. The experimental results indicated that the OTEs exhibited better antibacterial activity than the OPEs, the neutral OTEs exhibited better antibacterial activity in most cases, and OTEs bearing cyclic amino groups exhibited better antibacterial activity than those bearing acyclic ones in most cases. This study provides useful guidelines for further antibacterial reagent design and investigations.


Asunto(s)
Alquinos/farmacología , Antibacterianos/farmacología , Tiofenos/farmacología , Alquinos/química , Alquinos/efectos de la radiación , Alquinos/toxicidad , Antibacterianos/química , Antibacterianos/efectos de la radiación , Antibacterianos/toxicidad , Línea Celular , Escherichia coli/efectos de los fármacos , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Luz , Pruebas de Sensibilidad Microbiana , Staphylococcus aureus/efectos de los fármacos , Tiofenos/química , Tiofenos/efectos de la radiación , Tiofenos/toxicidad
9.
Reprod Toxicol ; 101: 81-92, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33713778

RESUMEN

Redox regulation during metazoan development ensures that coordinated metabolic reprogramming and developmental signaling are orchestrated with high fidelity in the hypoxic embryonic environment. Valproic acid (VPA), an anti-seizure medication, is known to increase markers of oxidation and also increase the risk of neural tube defects (NTDs) when taken during pregnancy. It is unknown, however, whether oxidation plays a direct role in failed neural tube closure (NTC). Spatial and temporal fluctuations in total glutathione (GSH) and total cysteine (Cys) redox steady states were seen during a 24 h period of CD-1 mouse organogenesis in untreated conceptuses and following exposure to VPA and the Nrf2 antioxidant pathway inducer, 1,2-dithiole-3-thione (D3T). Glutathione, glutathione disulfide (GSSG), and Cys, cystine (CySS) concentrations, measured in conceptal tissues (embryo/visceral yolk sac) and fluids (yolk sac fluid/amniotic fluid) showed that VPA did not cause extensive and prolonged oxidation during the period of NTC, but instead produced transient periods of oxidation, as assessed by GSH:GSSG redox potentials, which revealed oxidation in all four conceptal compartments at 4, 10, and 14 h, corresponding to the period of heartbeat activation and NTC. Other changes were tissue and time specific. VPA treatment also reduced total FITC-Ab clearance from the medium over 3 h, indicating potential disruption of nutritive amino acid supply. Overall, these results indicated that VPA's ability to affect cellular redox status may be limited to tissue-specific windows of sensitivity during the period of NTC. The safety evaluation of drugs used during pregnancy should consider time and tissue specific redox factors.


Asunto(s)
Anticonvulsivantes/toxicidad , Antineoplásicos/toxicidad , Embrión de Mamíferos/efectos de los fármacos , Tionas/toxicidad , Tiofenos/toxicidad , Ácido Valproico/toxicidad , Aminoácidos/metabolismo , Animales , Cisteína/metabolismo , Embrión de Mamíferos/metabolismo , Femenino , Glutamato-Cisteína Ligasa/genética , Glutamato-Cisteína Ligasa/metabolismo , Glutatión/metabolismo , Hemo-Oxigenasa 1/genética , Hemo-Oxigenasa 1/metabolismo , Intercambio Materno-Fetal , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , NAD(P)H Deshidrogenasa (Quinona)/genética , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Organogénesis/efectos de los fármacos , Oxidación-Reducción , Embarazo
10.
Psychopharmacology (Berl) ; 238(7): 1847-1856, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33770233

RESUMEN

Recreational use of illicit methiopropamine (MPA) is a public health concern because it produces neurochemical effects comparable with those induced by methamphetamine (METH). The present study investigated the effects of MPA on the expression of an aggressive behaviour. Eighty CD-1 male mice, after receiving intraperitoneal injection of saline, MPA (0.01-10 mg/kg), METH (0.01-10 mg/kg), or AMPH (0.01-10 mg/kg), once a week over a 5-week period, underwent the resident-intruder test and spontaneous locomotor activity measurement. Results showed that all psychostimulants induce aggressive behaviour even at low doses, with a dose-dependent increase and a time-dependent sensitisation. MPA potency was similar to METH and superior to AMPH. Therefore, MPA-induced aggressive behaviour may appear even at MPA dosages free of cardiovascular or other behavioural adverse effects and could become a non-intentional side effect that users experience after increasing and repeating MPA consumption.


Asunto(s)
Agresión/efectos de los fármacos , Locomoción/efectos de los fármacos , Metanfetamina/análogos & derivados , Tiofenos/administración & dosificación , Tiofenos/toxicidad , Agresión/fisiología , Animales , Estimulantes del Sistema Nervioso Central/administración & dosificación , Estimulantes del Sistema Nervioso Central/química , Estimulantes del Sistema Nervioso Central/toxicidad , Relación Dosis-Respuesta a Droga , Locomoción/fisiología , Masculino , Metanfetamina/administración & dosificación , Metanfetamina/química , Metanfetamina/toxicidad , Ratones , Ratones Endogámicos ICR , Tiofenos/química
11.
Nanoscale Horiz ; 6(2): 177-185, 2021 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-33443277

RESUMEN

Photodynamic therapy (PDT) synergized photothermal therapy (PTT) shows superior clinical application prospects than single PDT or PTT. On the other hand, multimodal imaging can delineate comprehensive information about the lesion site and thus help to improve therapy accuracy. However, integrating all these functions into one single molecule is challenging, let alone balancing and maximizing the efficacy of each function. Herein, a near-infrared (NIR) small molecule (ETTC) with an "acceptor-donor-acceptor" structure was designed and synthesized by coupling rigity and flexibility to simultaneously achieve NIR-II fluorescence imaging (NIR-II FLI), photoacoustic imaging, PTT and PDT. The efficacy of each functionality was well balanced and optimized (NIR-II quantum yield: 3.0%; reactive oxygen species generation: 3.2-fold higher than ICG; photothermal conversion efficiency: 52.8%), which may be attributed to the coupling of the rigid and flexible structures in ETTC to tactically manipulate the energy dissipation paths (non-radiative against radiative decay). As a proof-of-concept, under the effective guidance of local-tumor imaging by PA and whole-body imaging by NIR-II FL, complete tumor eradication was achieved via PDT and PTT combinational therapy. This work provides a novel perspective into conceiving and developing single molecule for efficient versatile biomedical applications.


Asunto(s)
Antineoplásicos/uso terapéutico , Colorantes Fluorescentes/uso terapéutico , Neoplasias/diagnóstico por imagen , Neoplasias/tratamiento farmacológico , Tiofenos/uso terapéutico , Células A549 , Animales , Antineoplásicos/síntesis química , Antineoplásicos/toxicidad , Femenino , Colorantes Fluorescentes/síntesis química , Colorantes Fluorescentes/toxicidad , Humanos , Rayos Infrarrojos , Ratones Endogámicos BALB C , Ratones Desnudos , Imagen Multimodal/métodos , Fotoquimioterapia/métodos , Terapia Fototérmica/métodos , Medicina de Precisión/métodos , Tiofenos/síntesis química , Tiofenos/toxicidad , Ensayos Antitumor por Modelo de Xenoinjerto
12.
J Appl Toxicol ; 41(9): 1367-1379, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-33314207

RESUMEN

Worldwide demand for petroleum products has resulted in increased oil and gas activities in many countries. Conventional and unconventional oil and gas extraction, production, and transport lead to increased levels of petroleum-derived polycyclic aromatic hydrocarbons (PAHs) in the environment. PAH exposure has profound effects on reproduction by affecting pathways involved in placental trophoblast cell function and impairing normal placental development and function-key contributors to reproductive success. However, other components found in petroleum and wastewaters from oil and gas extraction, including the sulfur-containing heterocyclic aromatic compounds such as dibenzothiophene (DBT) and its alkylated derivatives, may also impact reproductive success. The goal of this study was to examine the effect of exposure to DBT, a compound commonly detected in the environment, and one of its alkylated analogues, 2,4,7-trimethyldibenzothiophene (2,4,7-DBT), on steroidogenic and angiogenic pathways critical for mammalian development in placental trophoblast cells (HTR-8/SVneo cells). 2,4,7-DBT but not DBT increased estradiol output in association with increased tube-like formation (surrogate for angiogenesis). These changes in angiogenesis did not appear to be related to altered expression of the key placental angiogenic gene targets (ANGPTL4, VEGFA, and PGF). Neither compound showed a concentration related effect on progesterone synthesis or its receptor expression. Our results suggest that 2,4,7-DBT can disrupt key pathways important for placental trophoblast function and highlight the importance of determining the impact of exposure to both parent and alkylated compounds. Further, these data suggest that exposure to sulfur-containing heterocyclic aromatic compounds may lead to placental dysfunction and impact reproductive success at environmentally relevant levels.


Asunto(s)
Placenta/efectos de los fármacos , Tiofenos/toxicidad , Trofoblastos/efectos de los fármacos , Alquilación , Proteína 4 Similar a la Angiopoyetina/efectos de los fármacos , Proteína 4 Similar a la Angiopoyetina/genética , Línea Celular , Disruptores Endocrinos/toxicidad , Estradiol/metabolismo , Femenino , Humanos , Industrias , Neovascularización Fisiológica/efectos de los fármacos , Petróleo , Embarazo , Prostaglandinas F/metabolismo , Tiofenos/química , Factor A de Crecimiento Endotelial Vascular/efectos de los fármacos , Factor A de Crecimiento Endotelial Vascular/genética
13.
Br J Clin Pharmacol ; 87(3): 1327-1337, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-32789966

RESUMEN

AIM: Raltitrexed (RTX) is a thymidylate synthase inhibitor with large pharmacokinetics (PK) variability that can be administered in case of 5-fluorouracil (5FU) intolerance or dihydropyrimidine dehydrogenase deficiency. While it is a more potent thymidylate synthase inhibitor than 5FU, RTX failed to replace this drug for colorectal cancer patients, mainly due to its toxicity at the recommended dose of 3 mg/m2 every 3 weeks. However, every 2 weeks administration at 2 mg/m2 demonstrated a favourable toxicity profile. METHOD: We performed a randomized crossover comparative population PK study between every 2 weeks TOMOX (RTX 2 mg/m2 ) and every 3 weeks TOMOX (RTX 3 mg/m2 ). RESULTS: A three-compartment model and a proportional error model best describe the data. Creatinine clearance and sex, but not body surface area (BSA), were covariates of RTX clearance leading to decrease of its interindividual variability of 28%. Weight and body surface area were covariates of central and peripheral volumes of distribution, respectively, leading to decreases of interindividual variability of 34.6% and 100%, respectively. In contrast to the dose, AUC was a good predictor of liver toxicity (P = 0.006, OR = 3.91, 95%CI = [1.48-10.34]). Using covariates to compute individual clearance and a threshold AUC (1.639, determined in this study), a covariates-based dose was calculated, leading to less variability in AUC than observed with the actual BSA-based or fixed doses. CONCLUSION: These results advocate for the use of creatinine clearance and sex to determine the RTX dose instead of BSA.


Asunto(s)
Quinazolinas , Tiofenos , Estudios Cruzados , Fluorouracilo , Humanos , Hígado , Quinazolinas/efectos adversos , Tiofenos/toxicidad
14.
J Mater Chem B ; 8(46): 10609-10615, 2020 12 08.
Artículo en Inglés | MEDLINE | ID: mdl-33136104

RESUMEN

In this work, an anionic conjugated polyelectrolyte (PCP-SO3K), in which the backbone contains alternating 4,4-bis-alkyl-4H-cyclopenta-[2,1-b;3,4-b']-dithiophene and benzene structural units and the charges are provided by pendant sulfonate groups, was synthesized. The ionic nature of PCP-SO3K renders it soluble in water, and PCP-SO3K aqueous solution exhibits good photostability, with two main absorbance bands centered at 490 nm and 837 nm before and after laser irradiation. Its NIR absorption in water, negligible photoluminescence and insignificant intersystem crossing endow PCP-SO3K with efficient photothermal therapy performance, and an effective photothermal conversion efficiency of 56.7% was realized. Thus, PCP-SO3K aqueous solution can be used as an effective photothermal agent for in vivo applications as its photoactivity can be triggered by NIR light and can convert laser energy into thermal energy in a water environment. Of particular importance is the fact that complete tumor remission without recurrence in 4T1 tumor-bearing mice was realized after intravenous injection of PCP-SO3K aqueous solution and laser irradiation (2.0 W cm-2, 808 nm). The results indicate that the application of anionic conjugated polyelectrolytes as photothermal agents in photothermal therapy provides a new platform for the design of photothermal agents for clinical cancer treatment.


Asunto(s)
Antineoplásicos/uso terapéutico , Neoplasias/tratamiento farmacológico , Polielectrolitos/uso terapéutico , Ácidos Sulfónicos/uso terapéutico , Tiofenos/uso terapéutico , Animales , Antineoplásicos/efectos de la radiación , Antineoplásicos/toxicidad , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Femenino , Rayos Infrarrojos , Ratones Endogámicos BALB C , Terapia Fototérmica/métodos , Polielectrolitos/efectos de la radiación , Polielectrolitos/toxicidad , Ácidos Sulfónicos/efectos de la radiación , Ácidos Sulfónicos/toxicidad , Tiofenos/efectos de la radiación , Tiofenos/toxicidad
15.
Arch Pharm (Weinheim) ; 353(12): e2000103, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32893908

RESUMEN

The aim of this study was to synthesize newer potent Schiff bases by condensing 2-amino-5-(2,4-dichlorophenyl)thiophene-3-carbonitrile and 1,3-disubstituted-1H-pyrazole-4-carbaldehydes, and to investigate their biological activity. The compounds were synthesized via Gewald synthesis and characterized by spectral data and elemental analyses. They were screened for their in vitro antibacterial and anti-inflammatory activities. The synthesized compounds were also evaluated for in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv using the microplate Alamar Blue assay. Compounds 8b, 8c, 8f, 8g, 8k, 8n, and 8o showed promising antibacterial activity. The interactions between the substituted pyrazoles and bovine protein showed promising anti-inflammatory activity. The experimental results revealed compound 8a as a promising antitubercular agent. Hemolytic assays confirmed that the compounds are nontoxic, with percentage hemolysis ranging from 3.6 to 20.1, at a concentration of 1 mg/ml. The results suggest that the pyrazole ring and the substitution pattern on the heterocyclic moiety have an effect on the bioactivity.


Asunto(s)
Antibacterianos/farmacología , Antiinflamatorios/farmacología , Bacterias/efectos de los fármacos , Pirazoles/farmacología , Tiofenos/farmacología , Antibacterianos/síntesis química , Antibacterianos/toxicidad , Antiinflamatorios/síntesis química , Antiinflamatorios/toxicidad , Antituberculosos/síntesis química , Antituberculosos/farmacología , Antituberculosos/toxicidad , Bacterias/crecimiento & desarrollo , Diseño de Fármacos , Hemólisis/efectos de los fármacos , Humanos , Estructura Molecular , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/crecimiento & desarrollo , Pirazoles/síntesis química , Pirazoles/toxicidad , Bases de Schiff , Relación Estructura-Actividad , Tiofenos/síntesis química , Tiofenos/toxicidad
16.
Chemosphere ; 261: 127756, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32731027

RESUMEN

Urgent need for treatments limit studies of therapeutic drugs before approval by regulatory agencies. Analyses of drugs after approval can therefore improve our understanding of their mechanism of action and enable better therapies. We screened a library of 1443 Food and Drug Administration (FDA)-approved drugs using a simple assay in the nematode C. elegans and found three compounds that caused morphological changes. While the anticoagulant ticlopidine and the antifungal sertaconazole caused both accumulations that resulted in distinct distortions of pharyngeal anatomy and lethality upon acute exposure, the proton-pump inhibitor dexlansoprazole caused molting defects and required exposure during larval development. Such easily detectable defects in a powerful genetic model system advocate the continued exploration of current medicines using a variety of model organisms to better understand drugs already prescribed to millions of patients.


Asunto(s)
Bioacumulación/efectos de los fármacos , Caenorhabditis elegans/efectos de los fármacos , Dexlansoprazol/toxicidad , Imidazoles/toxicidad , Muda/efectos de los fármacos , Tiofenos/toxicidad , Ticlopidina/toxicidad , Animales , Caenorhabditis elegans/genética , Caenorhabditis elegans/crecimiento & desarrollo , Caenorhabditis elegans/metabolismo , Dexlansoprazol/metabolismo , Aprobación de Drogas , Epigénesis Genética/efectos de los fármacos , Humanos , Imidazoles/metabolismo , Larva/efectos de los fármacos , Larva/genética , Larva/crecimiento & desarrollo , Larva/metabolismo , Mutación , Tiofenos/metabolismo , Ticlopidina/metabolismo , Estados Unidos , United States Food and Drug Administration
17.
Toxicol Lett ; 332: 202-212, 2020 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-32659469

RESUMEN

A variety of methods have been developed for accurate and systematic evaluation of chemical genotoxicity. Ceric ammonium nitrate (CAN) and 1,3-propane sultone (1,3-PS) have been extensively applied in industrial fields. Although 1,3-PS, but not CAN, has been reported as a potent carcinogen, systematic assessment of the genotoxic properties of these chemicals has not been conducted. The purpose of this study was to establish a decision tree for evaluating genotoxicity based on the good laboratory practices (GLP) system using 1,3-PS and CAN as test chemicals. In vitro studies were performed including the bacterial reverse mutation assay, chromosomal aberration assay, and micronucleus assay. We conducted in vivo studies using a combined micronucleus and alkaline comet (MN-CMT) assay and the Pig-a gene mutation assay, which is a promising method for detecting gene mutations in vivo. CAN showed negative responses in all in vitro genotoxicity assays and the in vivo combined MN-CMT assay. Meanwhile, 1,3-PS had positive results in all in vitro and in vivo genotoxicity assays. In this study, we confirmed the genotoxicity of 1,3-PS and CAN using both in vitro and in vivo assays. We propose a decision tree for evaluating chemical-induced genotoxicity.


Asunto(s)
Cerio/toxicidad , Árboles de Decisión , Mutágenos/toxicidad , Tiofenos/toxicidad , Animales , Bacterias/efectos de los fármacos , Línea Celular/efectos de los fármacos , Aberraciones Cromosómicas/efectos de los fármacos , Ensayo Cometa , Cricetinae , Cricetulus , Daño del ADN , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Pruebas de Micronúcleos , Pruebas de Mutagenicidad , Ratas Sprague-Dawley
18.
Mutagenesis ; 35(4): 349-358, 2020 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-32608486

RESUMEN

The in vivo Pig-a assay is being used in safety studies to evaluate the potential of chemicals to induce somatic cell gene mutations. Ongoing work is aimed at developing an Organisation for Economic Cooperation and Development (OECD) test guideline to support routine use for regulatory purposes (OECD project number 4.93). Among the details that will need to be articulated in an eventual guideline are recommended treatment and harvest schedules. With this in mind, experiments reported herein were performed with Wistar Han rats exposed to aristolochic acid I (AA), 1,3-propane sultone, chlorambucil, thiotepa or melphalan using each of two commonly used treatment schedules: 3 or 28 consecutive days. In the case of the 3-day studies, blood was collected for Pig-a analysis on days 15 or 16 and 29 or 30. For the 28-day studies blood was collected on day 29 or 30. The effect of treatment on mutant reticulocytes and mutant erythrocytes was evaluated with parametric pair-wise tests. While each of the five mutagens increased mutant phenotype cell frequencies irrespective of study design, statistical significance was consistently achieved at lower dose levels when the 28-day format was used (e.g. 2.75 vs 20 mg/kg/bw for AA). To more thoroughly investigate the dose-response relationships, benchmark dose (BMD) analyses were performed with PROAST software. These results corroborate the pair-wise testing results in that lower BMD values were obtained with the 28-day design. Finally, mutagenic potency, as measured by BMD analyses, most consistently correlated with the mutagens' tumorigenic dose 50 values when the lengthier treatment schedule was used. Collectively, these results suggest that both 3- and 28-day treatment schedules have merit in hazard identification-type studies. That being said, for the purpose of regulatory safety assessments, there are clear advantages to study designs that utilise protracted exposures.


Asunto(s)
Proteínas de la Membrana/genética , Pruebas de Mutagenicidad/métodos , Mutágenos/toxicidad , Mutación , Reticulocitos/efectos de los fármacos , Animales , Ácidos Aristolóquicos/toxicidad , Clorambucilo/toxicidad , Eritrocitos/efectos de los fármacos , Masculino , Melfalán/toxicidad , Ratas , Ratas Wistar , Tiofenos/toxicidad , Tiotepa/toxicidad , Factores de Tiempo
19.
Cardiovasc Drugs Ther ; 34(1): 15-23, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-32062793

RESUMEN

PURPOSE: Drugs inhibiting the platelet P2Y12 receptor, such as clopidogrel and prasugrel, are potent antithrombotic agents and are widely used in cardiovascular disease. However, the adverse effects of these drugs have limited their clinical use. For example, clopidogrel resistance occurs in approximately one third of patients, while prasugrel increases the risk of major bleeding. Therefore, new generations of such drugs are of clinical interest. METHODS: In this study, the pharmacodynamics of a new P2Y12 antagonist, CN-218, was compared with that of clopidogrel and prasugrel in rats and mice. The differences between CN-218 and clopidogrel include deuteration of the 7-position methyl carboxylate and the introduction of cinnamate in the 2-position of thiophene. RESULTS: CN-218 had an antiaggregatory efficacy that was at least five times more potent than that of clopidogrel but not as potent as that of prasugrel. It had a significant impact on activated partial thromboplastin time (APTT), whereby the APTT of CN-218-treated rats was approximately 9 s longer than that of the vehicle- or clopidogrel-treated group, while it had no impact on prothrombin time (PT) in rats. CN-218 had a similar potent antithrombotic effect to that of prasugrel and clopidogrel and also reduced the risk of bleeding compared to prasugrel. CONCLUSION: CN-218 may be a promising antithrombotic agent, with potent antiplatelet and significant anticoagulant activity, as well as a lower risk of bleeding compared to clopidogrel and prasugrel.


Asunto(s)
Coagulación Sanguínea/efectos de los fármacos , Plaquetas/efectos de los fármacos , Fibrinolíticos/farmacología , Piperidinas/farmacología , Inhibidores de Agregación Plaquetaria/farmacología , Agregación Plaquetaria/efectos de los fármacos , Antagonistas del Receptor Purinérgico P2Y/farmacología , Receptores Purinérgicos P2Y12/efectos de los fármacos , Tiofenos/farmacología , Trombosis/prevención & control , Animales , Plaquetas/metabolismo , Carragenina , Clopidogrel/farmacología , AMP Cíclico/sangre , Modelos Animales de Enfermedad , Fibrinolíticos/toxicidad , Hemorragia/inducido químicamente , Masculino , Ratones , Piperidinas/toxicidad , Inhibidores de Agregación Plaquetaria/toxicidad , Clorhidrato de Prasugrel/farmacología , Antagonistas del Receptor Purinérgico P2Y/toxicidad , Ratas Wistar , Receptores Purinérgicos P2Y12/sangre , Tiofenos/toxicidad , Trombosis/sangre , Trombosis/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA